
The new variant is likely to cause severe symptoms. The findings of the pathogenicity evaluation show increased disease severity and point towards the need for screening of vaccine efficacy. The findings of the pre-print study has been published online on bioRxiv.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pxnopO
via
IFTTT
0 comments:
Post a Comment